Drug Trial Radar · NCT06493084
Evaluate LAE102 in Healthy and Overweight/Obese Subjects
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
160
Planned (sponsor's estimate)
Start
Jun 25, 2024
Primary completion
Jun 30, 2027
Study completion Dec 30, 2027
Sponsor
- Lead sponsor
- Laekna LimitedIndustry
- Sponsor type
- Industry
- First posted
- Jul 9, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of LAE102 injection in healthy and overweight/obese participants, and also evaluate the preliminary pharmacodynamic effect of multiple dose injections in overweight/obese participants.
Conditions
- Overweight and Obese Volunteers
Interventions
LAE102 intravenous administrationDrug
A single dose of LAE102 administered intravenously
placebo intravenous administrationDrug
A single dose of placebo administered intravenously
LAE102 subcutaneous administrationDrug
Single dose of LAE102 administered subcutaneously
placebo subcutaneous administrationDrug
single dose of placebo administered subcutaneously
LAE102 multiple subcutaneous administrationDrug
Multiple dose of LAE102 administered subcutaneously
Placebo multiple subcutaneous administrationDrug
Multiple dose of placebo administered subcutaneously
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number & severity of participants with treatment-related adverse events as assessed by CTCAE V5.0Time frame: From Day 1 to Day 29 for single dose part. From Day 1 to Day 196 for multiple dose part
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Fudan Zhongshan Hospital
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.